# Potential Role of Sirtuins As Epigenetic Biomarkers of the Patient with Atherosclerosis or Calcific Aortic Stenosis

> **NCT06337227** · — · RECRUITING · sponsor: **IRCCS SYNLAB SDN** · enrollment: 3 (estimated)

## Conditions studied

- Atherosclerosis and Calcific Aortic Stenosis with and Without Diabetes

## Interventions

- **DIAGNOSTIC_TEST:** lncRNA signature analyses

## Key facts

- **NCT ID:** NCT06337227
- **Lead sponsor:** IRCCS SYNLAB SDN
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-19
- **Primary completion:** 2025-10
- **Final completion:** 2026-10
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2025-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06337227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06337227, "Potential Role of Sirtuins As Epigenetic Biomarkers of the Patient with Atherosclerosis or Calcific Aortic Stenosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06337227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*